Navigation Links
Salt Lake City Medical Research Center Tests New Drug To Treat Painful Menstrual Cramps
Date:1/11/2010

SALT LAKE CITY, Jan. 11 /PRNewswire/ -- A leading clinical research center in Salt Lake City has joined an international trial program to test an experimental new drug designed to treat painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States. Although not life threatening, dysmenorrhea can be debilitating and psychologically taxing and is one of the leading causes of absenteeism from work and school.

Current therapies for the condition (including NSAIDs and 'off label' oral contraceptives) are not completely effective for all women and sometimes do not provide satisfactory relief of symptoms, particularly in women with more severe pain. The investigational new drug, presently named VA111913, is designed to tackle the cause of the cramps that can leave some women bedridden, rather than just the symptoms.

The Jean Brown Research center is recruiting women of childbearing age who suffer from dysmenorrhea and normally take medicines to treat their menstrual cramps to take part in a clinical research trial. The trial will assess the effect that treatment with VA111913 has on pain experienced during menstruation, including the intensity and duration of the pain.

Menstrual cramps are caused by contractions of the uterus during menstruation. In earlier studies, VA111913 has been shown to control abnormal contraction of smooth muscle, such as that found in the uterus wall. By targeting receptors of a hormone called vasopressin it is hoped the investigational new drug will prove effective in controlling the abnormal contractions that cause period pain.

The study, which involves centers in the US and the UK, is a Phase II trial designed to show whether the drug is effective in treating menstrual cramps. Results from this trial are expected in 2010 and if it, and further studies, are successful, the drug could be available in four years.

Dr. Yamashiro, the physician leading the trial at Jean Brown Research, said, "Dysmenorrhea affects a large number of women and there is currently no targeted therapy to treat the condition. Earlier results with this investigational new drug showed effects on the contraction of smooth muscle and it is hoped that VA111913 could potentially offer an effective treatment to the many women whose lives are affected by this painful and debilitating condition."

Physicians and patients interested in learning more about this clinical trial can contact Jean Brown Research at 801-261-2000 for more information and to find out if they are initially eligible to screen for the study.

The trial is being sponsored by UK-based company Vantia Therapeutics, which discovered the new drug.

SOURCE Jean Brown Research

RELATED LINKS
http://www.JeanBrownResearch.com

'/>"/>

SOURCE Jean Brown Research
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Inverness Medical Innovations to Present at the J.P. Morgan Healthcare Conference on January 12, 2010
2. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
3. ViVre Medical Announces $6,000,000 Gift
4. University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System
5. Hope International Centro de Radioterapia of Guatemala Becomes First in Latin America to Treat Cancer Using RapidArc(R) Radiotherapy Technology From Varian Medical Systems
6. FDA Advisory Panel Votes 15 to 0 in Favor of Approving Envoy Medicals Esteem(R) Fully Implantable Hearing Restoration System
7. Nonin Medical Announces Expanded Distribution Partnership With CareFusion
8. Symmetry Medical Announces Restructuring
9. Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
10. Cantel Medical Authorizes Semiannual Dividend
11. Connectyx Announces Distribution Partnership with United States Medical Supply
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... number of ,world firsts,: , TwinLink™ - ...
(Date:6/23/2016)... Research and Markets has announced ... Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, ... offering. Surgical Procedure ... planners, provides surgical procedure volume data in a geographic ... in-depth analysis of growth drivers and inhibitors, including world ...
(Date:6/23/2016)... , June 23, 2016  The National ... has joined the health policy research organization as ... Romano , MD, senior vice president and chief ... company,s representative on the NPC Board of Directors. ... pleased that Mallinckrodt has joined us in support ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
Breaking Medicine News(10 mins):